BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2010
View Archived Issues
Cytomics claims novel antiproliferative agents for multidrug resistance cancer
Read More
GPR119 agonists for the treatment of obesity identified by iNovacia
Read More
Organon presents AMPA receptor agonists for neurodegenerative diseases
Read More
Bayer Schering Pharma discovers novel c-Met inhibitors for cancer therapy
Read More
Sunesis completes enrollment of phase Ib/II voreloxin trial
Read More
ACT Biotech confirms FDA acceptance of ACTB-1003 IND
Read More
Locked nucleic acid-based oligonucleotide suppresses HCV viremia in primates
Read More
Droxidopa restores contextual memory in mouse model of Down's syndrome
Read More
Cetuximab as first-line therapy for Menetrier's disease / News in Context
Read More
GlaxoSmithKline receives approval for Arepanrix H1N1 vaccine
Read More
Gentamicin induces readthrough of termination codons in Stuve-Wiedermann syndrome
Read More
Novartis obtains approval for new H1N1 flu vaccine
Read More
AFFiRiS discloses novel therapeutics for beta-amyloidoses
Read More
Novel monoamine reuptake inhibitors in development at SK Holdings
Read More
Inspire reports results of phase III Prolacria trial for dry eye
Read More
Somaxon provides update on Silenor NDA for the treatment of insomnia
Read More
Agennix expands phase III talactoferrin registration trial globally
Read More
Arzerra receives positive opinion for conditional approval in Europe for CLL
Read More
CytRx reports 2010 clinical and development milestones
Read More
GAA gene variants responsive to Pompe's disease candidate AT-2220 identified
Read More
OVATURE trial analysis to proceed following database lock
Read More
Sinovac presents recent developments for its vaccines
Read More
EMEA validates NicOx's MAA for naproxcinod in primary osteoarthritis
Read More
Pharming presents update on European CHMP's review of MAA for Rhucin in HAE
Read More
EMEA completes validation phase of MAA for Pfizer and Auxilium's Xiaflex
Read More
FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients
Read More